SIGA Technologies Inc (SIGA)
Featured in
High-Beta Stocks
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market in the United States. Its lead product is TPOXX, an antiviral medicine used in the treatment of human smallpox disease caused by the variola virus. The company was incorporated in 1995 and is headquartered in New York, New York. SIGA Technologies common stock is listed on NASDAQ under the ticker SIGA.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-SIGA
|
$3.76
|
6.4% Upside
|
Fair
|
—
|
—
|
—
|
Great
|
—
|
—
|
1.2
|
0.0%
|
July 30, 2026
|
12.5x
|
1.7x
|
2.7x
|
249.6 M
|
108.2 M
|
0.2%
|
57.2%
|
3.2
|
0.8%
|
135.5%
|
